The Journal of Clinical Investigation Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Publishing

Industry

Estimated Revenue & Valuation

  • The Journal of Clinical Investigation's estimated annual revenue is currently $4.4M per year.(i)
  • The Journal of Clinical Investigation's estimated revenue per employee is $170,100

Employee Data

  • The Journal of Clinical Investigation has 26 Employees.(i)
  • The Journal of Clinical Investigation grew their employee count by -7% last year.

The Journal of Clinical Investigation's People

NameTitleEmail/Phone
1
Author Services ManagerReveal Email/Phone
2
Copy EditorReveal Email/Phone
3
Executive EditorReveal Email/Phone
4
N/AReveal Email/Phone
5
Copy EditorReveal Email/Phone
6
Scientific IllustratorReveal Email/Phone
7
Science EditorReveal Email/Phone
8
Science Communications SpecialistReveal Email/Phone
9
Senior Science EditorReveal Email/Phone
10
Production EditorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3410%N/AN/A
#2
$8M41-7%N/AN/A
#3
$2.2M150%N/AN/A
#4
$64.7M2400%N/AN/A
#5
$7M366%N/AN/A
#6
$12.7M585%N/AN/A
#7
$29.9M1231%N/AN/A
#8
$46M17234%N/AN/A
#9
$4.4M26-28%N/AN/A
#10
$1532.9M450614%N/AN/A
Add Company

What Is The Journal of Clinical Investigation?

The Journal of Clinical Investigation (JCI) is a top-tier venue for discoveries in basic and clinical biomedical research that will advance the practice of medicine. Founded in 1924, the journal is published by the American Society for Clinical Investigation (ASCI) and has a 2016 Impact Factor of 13.251. Since 2012, the JCI has been headed by Dr. Gordon F. Tomaselli, Editor, with an Editorial Board of peer scientists at Johns Hopkins University. The JCI provides free access to all of its research articles

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4.4M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M2673%N/A
#2
$4.4M26-28%N/A
#3
N/A26-10%N/A
#4
$2.6M2618%N/A
#5
$1.9M26-26%N/A